Article
Artificial Intelligence for Genetic Cancer Risk Assessment in Gynecologic Oncology: A Review of the Current Landscape and Future Directions.
Clinical obstetrics and gynecology - 1 Mar 2026
Haghighat Roxanna, Levi Sarah R, Frey Melissa K
Abstract excerpt
Hereditary cancer syndromes are associated with up to 25% of ovarian and 5% of endometrial cancers, yet rates of genetic testing and counseling remain low. Artificial intelligence (AI) offers new opportunities to streamline risk assessment, enhance gene variant interpretation, and expand access to genetic counseling. This narrative review synthesizes current evidence on AI applications in gynecologic cancer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
